loader
Please Wait
Applying Filters...

List of Certificates of Suitability (CEPs) for r1_cep_1997_057___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Aventis Pharma Deutschland GmbH Frankfurt Am Main DE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

R1-CEP 1997-057 - Rev 00
Expired
Chemical and TSE
2004-05-25
2009-05-25
1144
Sanofi Company Banner

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Certificate Number : R1-CEP 1997-057 - Rev 00

Status : Expired

Issue Date : 2004-05-25

Type : Chemical and TSE

Substance Number : 1144

Sanofi Company Banner

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-057 - Rev 00 of Aventis Pharma Deutschland Gmbh Frankfurt Am Main De

Looking for Certificates of Suitability (CEPs) for R1-CEP 1997-057 - Rev 00 of Aventis Pharma Deutschland Gmbh Frankfurt Am Main De 1

20

Aventis Pharma Deutschland Gmbh Frankfurt Am Main De, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

One of their significant offerings is Protirelin, supported by a 'Expired' Certificate of Suitability (CEP) with the number R1-CEP 1997-057 - Rev 00

This Chemical and TSE Type CEP, issued on May 25, 2004, remains in force until May 25, 2009, ensuring its reliability within the pharmaceutical industry.

Substance Number 1144 associated with this CEP further emphasizes